Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dexcom Inc 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 USA

www.dexcom.com Employees: 9,600 P: 858-200-0200

Description:

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

Key Statistics

Overview:

Market Capitalization, $K 27,478,358
Enterprise Value, $K 29,346,258
Shares Outstanding, K 390,595
Annual Sales, $ 3,622 M
Annual Net Income, $ 541,500 K
Last Quarter Sales, $ 994,200 K
Last Quarter Net Income, $ 134,600 K
EBIT, $ 622,800 K
EBITDA, $ 808,800 K
60-Month Beta 1.17
% of Insider Shareholders 0.30%
% of Institutional Shareholders 97.75%
Float, K 389,423
% Float 99.70%
Short Volume Ratio 0.58

Growth:

1-Year Return -25.26%
3-Year Return -55.72%
5-Year Return 42.06%
5-Year Revenue Growth 251.13%
5-Year Earnings Growth 1,800.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.45 on 10/24/24
Next Earnings Date N/A
Earnings Per Share ttm 1.70
EPS Growth vs. Prev Qtr 4.65%
EPS Growth vs. Prev Year -10.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 06/13/22

DXCM Ratios

Ratio
Price/Earnings ttm 41.46
Price/Earnings forward 41.31
Price/Earnings to Growth 2.16
Return-on-Equity % 31.40%
Return-on-Assets % 10.58%
Profit Margin % 14.95%
Debt/Equity 1.23
Price/Sales 7.60
Price/Cash Flow 34.06
Price/Book 13.91
Book Value/Share 5.07
Interest Coverage -1.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar